Danaher returns a key business to growth, and we're raising our stock rating back to buy

16 hours ago 3
ARTICLE AD BOX

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 

Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

Read Entire Article